SCHEMBL7110386

SCHEMBL7110386

CCCCCOc1cc(-c2ccccc2)cc(-c2ccccc2)n1

nearest known ligand 0.68

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LTB4R Q15722 20/20 0.68
LTB4R2 Q9NPC1 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6946055 0.85 LTB4R (0.68) LTB4RLTB4R2
SCHEMBL14801927 0.84 CYP2D6 (0.57) LTB4R
SCHEMBL6756180 0.84 LTB4R (0.73) LTB4RLTB4R2
SCHEMBL6757528 0.84 LTB4R (0.71) LTB4RLTB4R2
SCHEMBL8987368 0.83 LTB4R (0.72) LTB4RLTB4R2
Ammonia Solution, Strong SCHEMBL6757534 0.83 LTB4R (0.73) LTB4RLTB4R2
SCHEMBL5331564 0.81 SOAT1 (0.50) LTB4R
SCHEMBL8987039 0.81 LTB4R (1.00) LTB4R
SCHEMBL6759770 0.81 LTB4R (0.73) LTB4R
SCHEMBL8987355 0.81 LTB4R (0.77) LTB4R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1347784-A2 SIMULTANEOUS DUAL ISOTOPE IMAGING OF CARDIAC PERFUSION AND CARDIAC INFLAMMATION Bristol-Myers Squibb Pharma Company (US) 2003-10-01 EP disclosed
WO-2002036173-A2 SIMULTANEOUS DUAL ISOTOPE IMAGING OF CARDIAC PERFUSION AND CARDIAC INFLAMMATION BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2002-05-10 WO disclosed